NCT06363266
A SMART Design to Optimize the Delivery of TEMPO for Men With Prostate Cancer and Their Caregivers
StatusRecruiting
PhaseNot applicable
Primary completion (estimated)
At risk: Primary completion moved at least 8 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 6 versions: 6 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary completion pushed from Oct 31, 2026 to Jun 30, 2027
- Interventions: Active Monitoring dyads' anxiety (Other), TEMPO (Behavioral) to Active Monitoring dyads' anxiety (Other), TEMPO (Behavioral)
- Secondary endpoints: details revised at 7 of 7 entries
- Site details revised at 2 of 2 sites
- Minor Start date changed from estimate of May 2025 to Aug 1, 2025v5
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date: Mar 1, 2025 to May 2025
- Site details revised at 2 of 2 sites
- Minor Secondary endpoints revised (7)
- Study description expanded, about 216 words
Notable Start date: Sep 1, 2024 to Mar 1, 2025v2 Show 7 more changesShow less
- Eligibility criteria expanded, about 43 words
- Primary endpoint revised
- Primary completion date: Aug 31, 2026 to Oct 31, 2026
- Secondary endpoints: 1 to 7
- Study description expanded, about 22 words
- Site details revised at 1 of 2 sites
- Collaborators revised (10)
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Anxiety
Timeframe: T0: Baseline; T1: 13 weeks post-baseline; T2: 25 weeks post-baseline
Secondary (7)
Perceived Stress Scale (PSS)
Patient-Reported Outcome Measurement Information System (PROMIS) Self-Efficacy Scale
Health Education Impact Questionnaire (heiQ)
Godin Leisure-Time Exercise Questionnaire (GLTEQ)
Dyadic Coping Inventory (DCI)
Show 2 moreShow less
SF-12
Hospital Anxiety and Depression Scale (HADS) depression subscale
Arms and interventions
TEMPOExperimental
Using a stepped care approach, TEMPO will be provided across two intervention stages with variations on timing (initial vs. delayed) and intensity (self-directed vs. guided). All dyads will continue to access usual care (a co-intervention measure is included).
Actively Monitoring dyads' anxietyActive comparator
Patients will receive usual care throughout the study.
Behavioral: TEMPO
Other: Active Monitoring dyads' anxiety
Sites
2 sites in 1 country